Trends in Pharmacological Sciences
ReviewMouse models of Huntington's disease
Section snippets
Knockout mice
Soon after the discovery of the gene mutation that causes HD, it was found that homozygous knockout of this gene in mice was embryonic lethal 8, 9, 10, which contrasts with the late onset of the disease in humans. Thus, these early mouse models are not good models of the disease but they do indicate that huntingtin has an essential role in embryonic development. Furthermore, mutant huntingtin can rescue the knockout phenotype, which indicates that the effect of the mutation is not primarily due
Transgenic mouse models of HD
The general characteristics and a summary of findings in transgenic mice are presented in Table 1 and Table 2.
Knock-in models of HD
In theory, knock-in models (Table 3) should be optimal to reproduce human pathology and test prospective treatments because they are the most faithful reproduction of the disease genotype. In practice, these models were disappointing initially because the mice showed either no behavioral phenotypes 11, 41 or anomalies that apparently did not involve movement disorders [42]. However, this initial disappointment has been dispelled by closer analysis and generation of additional models 43, 44. It
Curing HD: clues from mouse models
One striking observation that derives from comparing the mouse models described earlier is that mice expressing full-length mutated proteins have a less aggressive course of disease than mice that express a truncated form. This agrees with observations made in cell-based assays where long fragments of mutant huntingtin are less toxic to cells than short, N-terminal fragments containing the same number of CAG repeats [48]. This observation strongly indicates that specific proteolysis of
Concluding remarks
Eight years after the identification of the gene responsible for HD [3], the disease remains untreatable. However, major progress has been made in our understanding of HD and several avenues for rational therapeutic approaches are starting to open. Although work in vitro has contributed greatly, analysis of mouse models has been crucial to this progress because of the opportunity they provide to examine pathological, cellular and molecular events that occur at the early stages of the disease.
References (69)
Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes
Cell
(1995)Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
Cell
(1996)Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
Cell
(1997)Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?
Neuron
(1997)Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length
Neurobiol. Dis.
(1998)Mapping the basal ganglia
Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease
Exp. Neurol.
(2000)Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis
Neuroscience
(1995)- et al.
Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice
Neuroscience
(2000) Excitotoxic injury of the neostriatum: a model for Huntington's disease
Trends Neurosci.
(1990)
Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity
Brain Res. Bull.
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
Neuron
Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract
J. Biol. Chem.
Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice
Cell
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
Cell
Replicating Huntington's disease phenotype in experimental animals
Prog. Neurobiol.
Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease
Brain Res.
Huntington's Disease
Neuropathological classification of Huntington's disease
J. Neuropathol. Exp. Neurol.
A novel gene containing a trinucleotide repeat that is unstable on Huntington's Disease chromosomes
Cell
Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies
Proc. Natl. Acad. Sci. U. S. A.
Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease
Neurology
The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size
Am. J. Hum. Genet.
Fourteen and counting: unraveling trinucleotide repeat diseases
Hum. Mol. Genet.
Inactivation of the mouse Huntington's disease gene homolog Hdh
Science
Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue
Nat. Genet.
Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion
Nat. Genet.
Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice
Nat. Genet.
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
Science
Mouse Huntington's disease gene homolog (Hdh)
Somatic Cell Mol. Genet.
Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation
J. Neurosci.
Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes
Diabetes
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
Proc. Natl. Acad. Sci. U. S. A.
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
Science
Cited by (252)
Modeling Huntington's disease: An insight on in-vitro and in-vivo models
2024, Behavioural Brain ResearchMeasuring movement in health and disease
2022, Brain Research BulletinChallenges in progressing cell therapies to the clinic for Huntington's disease: A review of the progress made with pluripotent stem cell derived medium spiny neurons
2022, International Review of NeurobiologyGene-dosage- and sex-dependent differences in the prodromal-Like phase of the F344tgHD rat model for Huntington disease
2024, Frontiers in Neuroscience